239 related articles for article (PubMed ID: 34185288)
21. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
22. A novel signaling role for miR-451 in esophageal tumor microenvironment and its contribution to tumor progression.
Khazaei S; Nouraee N; Moradi A; Mowla SJ
Clin Transl Oncol; 2017 May; 19(5):633-640. PubMed ID: 27896643
[TBL] [Abstract][Full Text] [Related]
23. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated macrophages: implications in cancer immunotherapy.
Petty AJ; Yang Y
Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
[TBL] [Abstract][Full Text] [Related]
25. Elimination of NF-κB signaling in Vimentin+ stromal cells attenuates tumorigenesis in a mouse model of Barrett's Esophagus.
Anand A; Fang HY; Mohammad-Shahi D; Ingermann J; Baumeister T; Strangmann J; Schmid RM; Wang TC; Quante M
Carcinogenesis; 2021 Apr; 42(3):405-413. PubMed ID: 33068426
[TBL] [Abstract][Full Text] [Related]
26. Cellular changes in the tumor microenvironment of human esophageal squamous cell carcinomas.
Liu J; Li Z; Cui J; Xu G; Cui G
Tumour Biol; 2012 Apr; 33(2):495-505. PubMed ID: 22134872
[TBL] [Abstract][Full Text] [Related]
27. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.
Li J; Zeng Z; Jiang X; Zhang N; Gao Y; Luo Y; Sun W; Li S; Ren J; Gong Y; Xie C
Sci Rep; 2020 Oct; 10(1):18589. PubMed ID: 33122682
[TBL] [Abstract][Full Text] [Related]
28. The Molecular Biologic Basis of Esophageal and Gastric Cancers.
Pennathur A; Godfrey TE; Luketich JD
Surg Clin North Am; 2019 Jun; 99(3):403-418. PubMed ID: 31047032
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.
Yuan X; Li Y; Zhang AZ; Jiang CH; Li FP; Xie YF; Li JF; Liang WH; Zhang HJ; Liu CX; Pang LJ; Shen XH; Li F; Hu JM
Aging (Albany NY); 2020 Dec; 13(2):2049-2072. PubMed ID: 33323552
[TBL] [Abstract][Full Text] [Related]
30. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
Shigeoka M; Urakawa N; Nakamura T; Nishio M; Watajima T; Kuroda D; Komori T; Kakeji Y; Semba S; Yokozaki H
Cancer Sci; 2013 Aug; 104(8):1112-9. PubMed ID: 23648122
[TBL] [Abstract][Full Text] [Related]
31. Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors.
Chambers A; Kundranda M; Rao S; Mahmoud F; Niu J
Curr Oncol Rep; 2021 Jul; 23(9):100. PubMed ID: 34269922
[TBL] [Abstract][Full Text] [Related]
32. The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine.
Rimassa L; Personeni N; Aghemo A; Lleo A
J Autoimmun; 2019 Jun; 100():17-26. PubMed ID: 30862450
[TBL] [Abstract][Full Text] [Related]
33. Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.
Chen MF; Chen PT; Lu MS; Chen WC
Mol Carcinog; 2018 Jan; 57(1):78-88. PubMed ID: 28888039
[TBL] [Abstract][Full Text] [Related]
34. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis in esophageal and gastric cancer: a paradigm shift in treatment.
Barzi A; Thara E
Expert Opin Biol Ther; 2014 Sep; 14(9):1319-32. PubMed ID: 24881691
[TBL] [Abstract][Full Text] [Related]
36. NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.
Takase N; Koma Y; Urakawa N; Nishio M; Arai N; Akiyama H; Shigeoka M; Kakeji Y; Yokozaki H
Cancer Lett; 2016 Sep; 380(1):47-58. PubMed ID: 27317650
[TBL] [Abstract][Full Text] [Related]
37. Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial.
Wang S; Lin Y; Xiong X; Wang L; Guo Y; Chen Y; Chen S; Wang G; Lin P; Chen H; Yeung SJ; Bremer E; Zhang H
Clin Cancer Res; 2020 Sep; 26(18):4921-4932. PubMed ID: 32646922
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis-related molecular targets in esophageal cancer.
Hong L; Li S; Han Y; Du J; Zhang H; Li J; Zhao Q; Wu K; Fan D
Expert Opin Investig Drugs; 2011 May; 20(5):637-44. PubMed ID: 21443389
[TBL] [Abstract][Full Text] [Related]
39. Nuclear receptors as modulators of the tumor microenvironment.
Sherman MH; Downes M; Evans RM
Cancer Prev Res (Phila); 2012 Jan; 5(1):3-10. PubMed ID: 22135047
[TBL] [Abstract][Full Text] [Related]
40. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
